… There is a recent update in WHO classification of pancreatic neuroendocrine neoplasms (PanNENs).
Our aim is to analyse the latest management for patients with PanNENs according …

… genes that may be markers for human gastric carcinoid autonomy. These findings can then
… and novel therapeutic strategies in patients with ECL cell tumours. One of these molecular …

… (PanNENs) include a new category of pancreatic neuroendocrine tumor, … pancreatic
neuroendocrine carcinoma. However, pancreatic neuroendocrine tumor grade 3 and pancreatic …

… In light of the limited courses of action to treat many NCDs that currently have only
symptomatic or a handful of therapeutic options, development of novel therapeutic strategies to …

… In this review, we discuss the molecular and immunological mechanisms by which aberrant
… , and discuss the clinical challenges associated with targeting SRC in pancreatic cancer. …

… and use as a therapeutic target in various neuroendocrine tumors. Targeting signaling …
be instrumental for the design of novel therapeutic strategies for neuroendocrine tumors. …

… the cancer microenvironment toward metastasis. Here, we provide a novel strategy for
therapeutic antibody treatment to target cancer-derived EVs and inhibit the metastasis of breast …

… Molecular markers that predict PNET behavior are necessary to improve clinical decision-making…
We provide an algorithm that summarizes the treatment strategies for PNETs (Figure 1). …

… role of GSK3α/β in NETs and suggest that GSK3α/β inhibition could be a novel therapeutic
option in NETs, especially in combination with lovastatin or 5-FU, depending on tumor entity. …

… Treatment … cell lung cancer (SCLC), the most common neuroendocrine cancer with $33,000
cases per year in the US,2 or are extrapolated from the treatment of epithelial cancers of the …